AIM

AIM ImmunoTech Inc.

1.11

USD

AIM Earnings Reports

Positive Surprise Ratio

AIM beat 14 of 29 last estimates.

48%

Next Report

Date of Next Report

Mar 30, 2026

Estimate for Q4 25 (Revenue/ EPS)

-$0.97

Implied change from Q3 25 (Revenue/ EPS)

-100.00%

-37.82%

Implied change from Q4 24 (Revenue/ EPS)

-100.00%

-90.30%

AIM ImmunoTech Inc. earnings per share and revenue

On Nov 17, 2025, AIM reported earnings of -1.56 USD per share (EPS) for Q3 25, missing the estimate of -0.98 USD, resulting in a -59.43% surprise. Revenue reached 26.00 thousand, compared to an expected --, with a 0.00% difference. The market reacted with a -7.64% price change (close before vs. close after earnings).

Looking ahead to Q4 25, 3 analysts forecast an EPS of -0.97 USD, with revenue projected to reach -- USD, implying an decrease of -37.82% EPS, and decrease of -100.00% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Takeda Pharmaceutical Company Limited - ADR

Report Date

Jan 30, 2026 For Q3 26

Estimate

$34.44

Actual

$65.64

Surprise

+90.61%

FAQ

What were AIM ImmunoTech Inc.'s earnings and revenue for the latest quarter Q3 2025?

For Q3 2025, AIM ImmunoTech Inc. reported EPS of -$1.56, missing estimates by -59.43%, and revenue of $26.00K, 0% as expectations.

How did the market react to AIM ImmunoTech Inc.'s Q3 2025 earnings?

The stock price moved down -7.64%, changed from $1.44 before the earnings release to $1.33 the day after.

When is AIM ImmunoTech Inc. expected to report next?

The next earning report is scheduled for Mar 30, 2026.

What are the forecasts for AIM ImmunoTech Inc.'s next earnings report?

Based on 3 analysts, AIM ImmunoTech Inc. is expected to report EPS of -$0.97 and revenue of -- for Q4 2025.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.